日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization

免疫靶向RBD纳米颗粒可诱导交叉反应性、RBS导向的免疫应答,从而实现对SARS-CoV-2变异株的中和作用

Konrath, Kylie M; Liaw, Kevin; Tursi, Nicholas J; McCanna, Madison E; Warner, Bryce M; Gary, Ebony N; Zhu, Xizhou; Livingston, Cory; Monastra, Cara; Frase, Drew; Chokkalingam, Neethu; Huynh, Alana; Shupin, Nicholas; Bayruns, Kelly; Kriete, Sinja; Kim, Amber; Park, Joyce; Vendramelli, Robert; Truong, Thang; Tierney, Kevin; Azaransky, Kimberly; Moffat, Estella; Embury-Hyatt, Carissa; Beer, Lynn A; Solanke, Oreoluwa; Walker, Susanne N; Kalia, Richa; Tang, Hsin-Yao; Humeau, Laurent M P F; Smith, Trevor R F; Kobasa, Darwyn; Weiner, David B; Kulp, Daniel W

661. Phase 1, dose-escalation trial of the safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies (DMAb) in healthy adults

661. SARS-CoV-2 DNA编码单克隆抗体(DMAb)在健康成人中的安全性和药代动力学I期剂量递增试验

Dimnjaković, Jelena; Buble, Tamara; Brborović, Ognjen; Tebas, Pablo; Patel, Ami; Agnes, Joseph; Parzych, Elizabeth M; Baer, Amanda; Caturla, Maria; Ghosh, Sukanya; Purwar, Mansi; Bedanova, Nicole; Tsang, chungdhak; Morales, Knashawn; Amante, Dinah; Fisher, Paul D; Francica, Joe; Humeau, Laurent; Pallesen, Jesper; Eric Leon, Paul; Esser, Mark T; Smith, Trevor R F; Weiner, David B

FRI057 Drug Concentrations And Dosing Considerations For Mibavademab, A Novel Leptin Receptor Agonist, In Individuals With Generalized Lipodystrophy

FRI057 药物浓度和剂量考虑因素:Mibavademab(一种新型瘦素受体激动剂)在全身性脂肪营养不良患者中的应用

Popova, Inna E; Bair, Daniel A; Tate, Kenneth W; Parikh, Sanjai J; Foss de Freitas, Maria Cristina; DillGomes, Anabela; Neidert, Adam; Podgrabinska, Simona; Olenchock, Ben; SinhaRoy, Rababir; Harris, Charles Andrew; Akinci, Baris; Altarejos, Judith; Oral, Elif A; Tebas, Pablo; Agnes, Joseph; Giffear, Mary; Kraynyak, Kimberly A; Blackwood, Elliott; Amante, Dinah; Reuschel, Emma; Liu, Neiman; Purwar, Mansi; Christensen-Quick, Aaron; Andrade, Viviane M; Carter, Julie; Garufi, Gabriella; Diehl, Malissa; Sylvester, Albert; Morrow, Matthew P; Pezzoli, Patrick P; Kulkarni, Abhijeet J; Zaidi, Faraz I; Frase, Drew; Liaw, Kevin; Patel, Ami; Buttigieg, Karen R; Ervin, John E; Pawlicki, Jan; Gillespie, Elisabeth; Maricic, Igor; Schultheis, Katherine; Badie, Hedieh; Herring, Timothy A; Simon, Keiko O; Smith, Trevor R F; Ramos, Stephanie; Spitz, Robert; Lee, Jessica; Dallas, Michael; Brown, Ami Shah; Shea, Jacqueline E; Kim, J Joseph; Weiner, David; Broderick, Kate; McMullan, Trevor; Boyer, Jean; Humeau, Laurent; Mammen Jr., Mammen P; Mendell, Jeanne; Wang, Yuhuan; Olenchock, Ben A; Podgrabinska, Simona; Pagovich, Odelya E; Oral, Elif A; Brown, Rebecca J; Davis, John

Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model

在绵羊模型中研究DNA编码抗体疗法的临床相关剂量和药代动力学

Hollevoet, Kevin; Thomas, Debby; Compernolle, Griet; Vermeire, Giles; De Smidt, Elien; De Vleeschauwer, Stéphanie; Smith, Trevor R F; Fisher, Paul D; Dewilde, Maarten; Geukens, Nick; Declerck, Paul

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.

INO-4800 DNA疫苗对SARS-CoV-2的安全性和免疫原性:一项开放标签1期临床试验的初步报告

Tebas Pablo, Yang ShuPing, Boyer Jean D, Reuschel Emma L, Patel Ami, Christensen-Quick Aaron, Andrade Viviane M, Morrow Matthew P, Kraynyak Kimberly, Agnes Joseph, Purwar Mansi, Sylvester Albert, Pawlicki Jan, Gillespie Elisabeth, Maricic Igor, Zaidi Faraz I, Kim Kevin Y, Dia Yaya, Frase Drew, Pezzoli Patrick, Schultheis Katherine, Smith Trevor R F, Ramos Stephanie J, McMullan Trevor, Buttigieg Karen, Carroll Miles W, Ervin John, Diehl Malissa C, Blackwood Elliott, Mammen Mammen P, Lee Jessica, Dallas Michael J, Brown Ami Shah, Shea Jacqueline E, Kim J Joseph, Weiner David B, Broderick Kate E, Humeau Laurent M

Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets

雪貂接种 INO-4800 疫苗后,501Y.V1 和 501Y.V2 SARS-CoV-2 变种的活病毒中和作用

Riddell, Shane; Goldie, Sarah; McAuley, Alexander J; Kuiper, Michael J; Durr, Peter A; Blasdell, Kim R; Tachedjian, Mary; Druce, Julian D; Smith, Trevor R F; Broderick, Kate E; Vasan, Seshadri S

578. INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants

578. INO-4800 DNA疫苗可诱导针对全球SARS-CoV-2变异株的中和抗体和T细胞活性

Huangfu, Yonghao; Li, Qingshan; Yang, Weiwei; Bu, Qingwei; Yang, Lei; Tang, Jianfeng; Gan, Jie; Andrade, Viviane M; Christensen-Quick, Aaron; Agnes, Joseph; Tur, Jared; Reed, Charles C; Kalia, Richa; Marrero, Idania; Elwood, Dustin; Schultheis, Katherine; Purwar, Mansi; Reuschel, Emma; McMullan, Trevor; Pezzoli, Patrick; Kraynyak, Kimberly A; Sylvester, Albert; Mammen Jr., Mammen P; Tebas, Pablo; Kim, J Joseph; Weiner, David; Smith, Trevor R F; Ramos, Stephanie; Humeau, Laurent; Boyer, Jean; Broderick, Kate

One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.

SARS-CoV-2 合成 DNA 疫苗 INO-4800 的一剂或两剂方案可在非人灵长类动物攻毒模型中预防呼吸道疾病负担

Gooch Karen E, Smith Trevor R F, Salguero Francisco J, Fotheringham Susan A, Watson Robert J, Dennis Mike J, Handley Alastair, Humphries Holly E, Longet Stephanie, Tipton Tom, Sarfas Charlotte, Sibley Laura, Slack Gillian S, Rayner Emma, Ryan Kathryn A, Schultheis Katherine, Ramos Stephanie J, White Andrew, Charlton Sue, Sharpe Sally A, Gleeson Fergus, Humeau Laurent M, Hall Yper, Broderick Kate E, Carroll Miles W

Active Immunoprophylaxis and Vaccine Augmentations Mediated by a Novel Plasmid DNA Formulation

新型质粒DNA制剂介导的主动免疫预防和疫苗增强作用

Schommer, Nina N; Nguyen, Jacklyn; Yung, Bryan S; Schultheis, Katherine; Muthumani, Kar; Weiner, David B; Humeau, Laurent; Broderick, Kate E; Smith, Trevor R F

Delineating the Cellular Mechanisms Associated with Skin Electroporation

阐明与皮肤电穿孔相关的细胞机制

Schultheis, Katherine; Smith, Trevor R F; Kiosses, William B; Kraynyak, Kimberly A; Wong, Amelia; Oh, Janet; Broderick, Kate E